Shifaa M. Abdin

1.5k total citations · 1 hit paper
15 papers, 1.1k citations indexed

About

Shifaa M. Abdin is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Shifaa M. Abdin has authored 15 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Immunology. Recurrent topics in Shifaa M. Abdin's work include CAR-T cell therapy research (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and COVID-19 Clinical Research Studies (2 papers). Shifaa M. Abdin is often cited by papers focused on CAR-T cell therapy research (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and COVID-19 Clinical Research Studies (2 papers). Shifaa M. Abdin collaborates with scholars based in United Arab Emirates, Egypt and United States. Shifaa M. Abdin's co-authors include Hany A. Omar, Mohamed Haider, Gorka Orive, Dima W. Alhamad, Hasan Y. Alniss, Taleb H. Al‐Tel, Sara M. Elgendy, Dana M. Zaher, El‐Shaimaa A. Arafa and Mai F. Tolba and has published in prestigious journals such as PLoS ONE, Cancer Research and Life Sciences.

In The Last Decade

Shifaa M. Abdin

14 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nanostructured Lipid Carriers for Delivery of Chemotherapeutics: A Review

2020 307 citations Mohamed Haider, Shifaa M. Abdin et al. Pharmaceutics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shifaa M. Abdin United Arab Emirates	13	416	167	150	148	133	15	1.1k
Yang Wan China	18	544 1.3×	186 1.1×	65 0.4×	144 1.0×	61 0.5×	73	1.2k
Ranjeet Prasad Dash United States	21	441 1.1×	146 0.9×	138 0.9×	81 0.5×	55 0.4×	52	1.2k
Hemachand Tummala United States	19	341 0.8×	96 0.6×	114 0.8×	154 1.0×	67 0.5×	31	935
Gurdarshan Singh India	22	549 1.3×	181 1.1×	92 0.6×	73 0.5×	115 0.9×	73	1.4k
Gamaleldin I. Harisa Saudi Arabia	23	506 1.2×	139 0.8×	238 1.6×	93 0.6×	145 1.1×	88	1.5k
Estelle Henry Luxembourg	14	639 1.5×	89 0.5×	69 0.5×	70 0.5×	86 0.6×	19	1.2k
Qingqing Li China	16	321 0.8×	60 0.4×	75 0.5×	70 0.5×	98 0.7×	77	938
Xiaoyang Li China	12	680 1.6×	112 0.7×	79 0.5×	131 0.9×	108 0.8×	29	1.2k
Yogendra Nayak India	22	364 0.9×	87 0.5×	235 1.6×	51 0.3×	66 0.5×	81	1.3k
Yaw‐Syan Fu Taiwan	18	378 0.9×	57 0.3×	190 1.3×	68 0.5×	113 0.8×	60	1.2k

Countries citing papers authored by Shifaa M. Abdin

Since Specialization

Citations

This map shows the geographic impact of Shifaa M. Abdin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shifaa M. Abdin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shifaa M. Abdin more than expected).

Fields of papers citing papers by Shifaa M. Abdin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shifaa M. Abdin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shifaa M. Abdin. The network helps show where Shifaa M. Abdin may publish in the future.

Co-authorship network of co-authors of Shifaa M. Abdin

This figure shows the co-authorship network connecting the top 25 collaborators of Shifaa M. Abdin. A scholar is included among the top collaborators of Shifaa M. Abdin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shifaa M. Abdin. Shifaa M. Abdin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Abdin, Shifaa M., Arnold Kloos, Mi-Sun Jang, et al.. (2023). Scalable generation of functional human iPSC-derived CAR-macrophages that efficiently eradicate CD19-positive leukemia. Journal for ImmunoTherapy of Cancer. 11(12). e007705–e007705. 42 indexed citations

Fayed, Bahgat, Alshaimaa M. Hamoda, Shifaa M. Abdin, et al.. (2021). Potential targeting of Hep3B liver cancer cells by lupeol isolated from Avicennia marina. Archiv der Pharmazie. 354(9). e2100120–e2100120. 24 indexed citations

Abdin, Shifaa M., Mai F. Tolba, Dana M. Zaher, & Hany A. Omar. (2021). Nuclear factor-κB signaling inhibitors revert multidrug-resistance in breast cancer cells. Chemico-Biological Interactions. 340. 109450–109450. 52 indexed citations

Zaher, Dana M., et al.. (2021). Tangeretin boosts the anticancer activity of metformin in breast cancer cells via curbing the energy production. Phytomedicine. 83. 153470–153470. 17 indexed citations

Abdin, Shifaa M., et al.. (2021). CARs and beyond: tailoring macrophage-based cell therapeutics to combat solid malignancies. Journal for ImmunoTherapy of Cancer. 9(8). e002741–e002741. 31 indexed citations

Haider, Mohamed, et al.. (2020). Nanostructured Lipid Carriers for Delivery of Chemotherapeutics: A Review. Pharmaceutics. 12(3). 288–288. 307 indexed citations breakdown →

Soliman, Sameh S. M., Shifaa M. Abdin, Ahmed M. Almehdi, et al.. (2020). Effective targeting of breast cancer cells (MCF7) via novel biogenic synthesis of gold nanoparticles using cancer-derived metabolites. PLoS ONE. 15(10). e0240156–e0240156. 19 indexed citations

Elgendy, Sara M., et al.. (2020). Ferroptosis: An emerging approach for targeting cancer stem cells and drug resistance. Critical Reviews in Oncology/Hematology. 155. 103095–103095. 93 indexed citations

Abdin, Shifaa M., et al.. (2020). The dynamic association between COVID-19 and chronic disorders: An updated insight into prevalence, mechanisms and therapeutic modalities. Infection Genetics and Evolution. 87. 104647–104647. 51 indexed citations

10.

Abdin, Shifaa M., et al.. (2020). Tackling the cytokine storm in COVID-19, challenges and hopes. Life Sciences. 257. 118054–118054. 64 indexed citations

11.

Abdin, Shifaa M., Mai F. Tolba, Dana M. Zaher, & Hany A. Omar. (2020). Abstract 4107: The impact of NF-κB inhibition on the sensitivity of breast cancer cells to chemotherapy-induced apoptosis. Cancer Research. 80(16_Supplement). 4107–4107.

12.

Abdin, Shifaa M., et al.. (2019). Knowledge, attitude and practice of in-home medication disposal in U.A.E.. International Journal of Basic & Clinical Pharmacology. 8(4). 746–746. 2 indexed citations

13.

Abdin, Shifaa M., et al.. (2019). BACE1 inhibitors: Current status and future directions in treating Alzheimer's disease. Medicinal Research Reviews. 40(1). 339–384. 224 indexed citations

14.

Semreen, Mohammad H., et al.. (2018). Recent updates of marine antimicrobial peptides. Saudi Pharmaceutical Journal. 26(3). 396–409. 80 indexed citations

15.

Abdin, Shifaa M., Dana M. Zaher, El‐Shaimaa A. Arafa, & Hany A. Omar. (2018). Tackling Cancer Resistance by Immunotherapy: Updated Clinical Impact and Safety of PD-1/PD-L1 Inhibitors. Cancers. 10(2). 32–32. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact